Rectal cancer is the second most common cancer in large intestine. The prevalence and the number of young patients diagnosed with rectal cancer have made it as one of the major health problems in the world. With regard to the improved access to and use of modern screening tools, a number of new cases are diagnosed each year. Considering the location of the rectum and its adjacent organs, ma...

OBJECTIVE This study examines clinical management pathways for patients with suspected pancreatic cancer within a single United Kingdom Calman-Hine NHS cancer network with particular focus on referral patterns and the primary care-hospital specialist interface. METHODS A questionnaire-based study appraising responses from three key groups (general practitioners, gastrointestinal physicians an...

Summary At the European Society for Medical Oncology (ESMO) 2022 annual meeting, several pertinent studies in field of upper gastrointestinal cancer were presented. The most practice-changing study appeared to be Destiny-Gastric02 evaluating trastuzumab–deruxtecan as a second-line treatment option patients with Her2-positive gastric and gastroesophageal junction cancer. median overall survival ...

BACKGROUND Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastrointestinal perforations caused by bevacizumab are very rare in breast cancer. CASE PRESENTATION We...